SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN) today announced the appointment of Dr. Mostafa Ronaghi as Senior Vice President and Chief Technology Officer. As reported during Illumina’s July 22, 2008 second quarter earnings release, Dr. Ronaghi joined Illumina following the Company’s recent acquisition of Avantome, Inc., which closed on August 1, 2008. Among his other duties, Dr. Ronaghi will be responsible for leading the technology development effort at Illumina including the Avantome technology, which is a low-cost, long-read-length sequencing technique that complements Illumina’s current sequencing technologies.
